Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Autografting

Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival

Bone Marrow Transplantation volume 36, pages 1049–1052 (2005)Cite this article

Summary:

Allograft dendritic cell (DC) content has been identified as a predictor of relapse and event-free survival after allogeneic bone marrow transplantation. However, the prognostic importance of DCs has not been evaluated in the setting of autologous hematopoietic stem cell transplantation (HSCT). We prospectively determined pre-transplant and post transplant DC levels, including DC1 and DC2 subset levels, in 53 patients with diffuse large B-cell non-Hodgkin's lymphoma (DLBC NHL) undergoing autologous HSCT. Pre-transplant DCs were measured in the collected stem cell products and were therefore indicative of cell numbers infused directly into patients; post transplant analysis of DCs was performed on the peripheral blood of patients 6 weeks after the infusion of autologous stem cells. Higher pre-transplant levels of DC1 cells and total DCs were significantly associated with improved survival. Similarly, greater post transplant levels of total DCs and both subsets were significantly associated with survival. These findings suggest a relationship between DC reconstitution and survival following autologous HSCT for DLBC NHL. Strategies to increase autograft DC content or accelerate DC recovery after autologous HSCT might improve outcomes in this setting.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Caux C, Vanbervliet B, Massacrier C et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 1996; 184: 695–706.

    Article  CAS  PubMed  Google Scholar 

  2. Robinson SP, Patterson S, English N et al. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999; 29: 2769–2778.

    Article  CAS  PubMed  Google Scholar 

  3. O'Doherty U, Peng M, Gezelter S et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994; 82: 487–493.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. O'Neill DW, Adams S, Bhardwaj N . Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 2004; 104: 2235–2246.

    Article  CAS  PubMed  Google Scholar 

  5. Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 1183–1186.

    Article  CAS  PubMed  Google Scholar 

  6. Parmiani G, Castelli C, Dalerba P et al. Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going? J Natl Cancer Inst 2002; 94: 805–818.

    Article  CAS  PubMed  Google Scholar 

  7. Waller EK, Rosenthal H, Jones TW et al. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 2001; 97: 2948–2956.

    Article  CAS  PubMed  Google Scholar 

  8. Savary CA, Grazziutti ML, Melichar B et al. Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients. Cancer Immunol Immunother 1998; 45: 234–240.

    Article  CAS  PubMed  Google Scholar 

  9. Fearnley DB, Whyte LF, Carnoutsos SA et al. Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood 1999; 93: 728–736.

    CAS  PubMed  Google Scholar 

  10. Damiani D, Stocchi R, Masolini P et al. Dendritic cell recovery after autologous stem cell transplantation. Bone Marrow Transplant 2002; 30: 261–266.

    Article  CAS  PubMed  Google Scholar 

  11. Bolwell B, Sobecks R, Pohlman B et al. Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone. Bone Marrow Transplant 2003; 31: 95–98.

    Article  CAS  PubMed  Google Scholar 

  12. Zhang H . Recursive Partitioning in the Health Sciences. Springer: New York, NY, 1999.

    Book  Google Scholar 

  13. Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C . Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000; 18: 1360–1377.

    Article  CAS  PubMed  Google Scholar 

  14. Porrata LF, Litzow MR, Inwards DJ et al. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 2004; 33: 291–298.

    Article  CAS  PubMed  Google Scholar 

  15. DeAngelo DJ, Alyea EP, Borrello IM et al. Posttransplant immunotherapy with a GM-CSF-based tumor vaccine (GVAX®) following autologous stem cell transplant (ASCT) for acute myeloid leukemia (AML). Session Type: Oral Session. Blood 2004; 104: 441 (abstract).

  16. Kronin V, Winkel K, Suss G et al. A subclass of dendritic cells regulates the response of naive CD8T cells by limiting their IL-2 production. J Immunol 1996; 157: 3819–3827.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are indebted to Ms Victoria Wentling for her invaluable assistance in preparing this manuscript.

Author information

Authors and Affiliations

  1. Department of Hematology and Medical Oncology, Bone Morrow Trasplant Program, Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH, USA

    R Dean, P Masci, B Pohlman, S Andresen, S Serafino, R Sobecks, E Kuczkowski, J Curtis, J Maciejewski, M Kalaycio & B J Bolwell

  2. Department of Biostatistics and Epidemiology, Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH, USA

    L Rybicki

  3. Department of Pathology Medicine, The Cleveland Clinic Foundation, Cleveland, OH, USA

    E Hsi & K Theil

Authors
  1. R Dean
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Masci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B Pohlman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Andresen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Serafino
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R Sobecks
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E Kuczkowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J Curtis
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J Maciejewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. L Rybicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M Kalaycio
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. E Hsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. K Theil
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. B J Bolwell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B J Bolwell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dean, R., Masci, P., Pohlman, B. et al. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival. Bone Marrow Transplant 36, 1049–1052 (2005). https://doi.org/10.1038/sj.bmt.1705183

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705183

Keywords

This article is cited by

Search

Advanced search

Quick links